Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

PRE-I-SPY Phase I/Ib Oncology Platform Program

NCT05868226

Conditions
Breast Diseases, Breast Neoplasms, ER Positive Breast Cancer, +29 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Recruiting

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

NCT04872166

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • The Linder Research Center at The Christ Hospital Cincinnati, Ohio, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study

NCT04170634

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +14 more
Locations
  • Service de rhumatologie, CHU d'Angers Angers, France
  • Ch Annecy Genevois Annecy, France
  • Service de radiothérapie, Institut Jean-Perrin Clermont-Ferrand, France
  • Service de rhumatologie, CH Annemasse Contamine-sur-Arve, France
View Trial Details
Recruiting

Comprehensive Outcomes for After Cancer Health

NCT05349227

Conditions
Adnexal Diseases, Behavior, Breast Cancer, +53 more
Locations
  • The University of Florida Gainesville, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions